GREENWICH LIFESCIENCES INC
(NASDAQ: GLSI)

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

13.120

+0.070 (+0.54%)
Range 12.680 - 14.136   (11.48%)
Open -
Previous Close 13.050
Bid Price 11.320
Bid Volume 9
Ask Price 12.130
Ask Volume 10
Volume 42,372
Value -
Remark
Delayed prices. Updated at 19 Apr 2024 03:58.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis